Skip to main content
. 2021 Jul 23;22(15):7892. doi: 10.3390/ijms22157892

Table 4.

Minimal concentrations inhibiting further growth of biofilm cells, biofilm reduction and biofilm metabolic activity with their respective inhibitory rates of PtNPs for biofilms. Data represent the mean of at least three independent replicates. The significance of the results was verified by t-test (p ≤ 0.05).

BACTERIAL STRAIN PtNPs
(mg/L)
MICBC80 A620
Inhibition (%)
MICBR80 A595
Inhibition (%)
MICMPB80 A595
Inhibition (%)
S. aureus 816 101 87.3 ± 5.4 101 84.5 ± 0.5 101 100.0 ± 0.0
S. aureus 1241 101 87.2 ± 4.6 101 83.0 ± 2.3 101 100.0 ± 0.0
L. monocytogenes 149 101 98.8 ± 2.3 >101 34.2 ± 5.2 101 99.6 ± 15.6
L. monocytogenes 164 101 95.8 ± 1.9 >101 68.1 ± 12.9 101 97.2 ± 2.8
E. coli 683/17 50.5 78.0 ± 4.5 >101 14.2 ± 24.3 101 98.9 ± 2.2
E. coli 693/17 50.5 80.7 ± 2.3 >101 15.6 ± 21.2 101 97.8 ± 2.2
E. coli 815 101 95.4 ± 0.2 >101 3.9 ± 6.6 101 87.6 ± 12.4
E. coli 859 50.5 81.8 ± 2.9 >101 53.9 ± 1.4 101 100.0 ± 0.0
S. Infantis S13 101 98.9 ± 0.1 >101 31.5 ± 27.0 101 100.0 ± 0.0
S. Infantis S59 101 99.1 ± 0.5 >101 42.2 ± 13.2 101 100.0 ± 2.5

PtNPs: 101, 50.5, 25.25, 12.63, 6.3, 3.16 mg/L (6 different concentrations); bold font marks the efficiency of ≥80%; MICBC80 marks minimum inhibitory concentrations for further growth of biofilm cells; MICBR80 marks minimum inhibitory concentrations for biofilm reduction; MICMPB80 marks minimum inhibitory concentrations for metabolic activity of preformed biofilm.